Reliability and Validity of the Valued Activity Inventory for Adults with Cancer

Abstract

The authors assessed the psychometric properties of the Valued Activity Inventory for Adults With Cancer (VAI-AC), a self-report instrument that measures activity limitations. Participants included 50 older adults undergoing chemotherapy who completed the VAI-AC and measures of physical and mental function, symptom intensity, and mood 3 days before and the day of chemotherapy. Test—retest reliability was assessed by determining the average number of items for which the importance of an activity was rated consistently and by calculating the intraclass correlation coefficient (ICC) for the first and second VAI-AC scores. Convergent validity was assessed by correlating the VAI-AC scores with the other measures. Participants consistently rated the importance of 90% of the items. The 72-hour test—retest reliability ICC was 0.67. Participants with fewer activity limitations indicated better physical function (r = 0.58, p < .001), better mental function (r = 0.55, p < .001), lower symptom intensity (r = −0.57, p < .001), and fewer depressive symptoms (r = −0.68, p < .001). The VAI-AC demonstrated evidence of test—retest reliability and convergent validity in this convenience sample of older adults undergoing chemotherapy for cancer.

Keywords

outcome and process assessment (health care)human activities

Get full access to this article

View all access options for this article.

References

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: Author.

Baum

C. M.

, & Edwards

(2008). Activity card sort (2nd ed.). Bethesda, MD: AOTA Press.

Bruce

M. L.

(2000). Depression and disability. In Williamson

G. M.

Shaffer

D. R.

, & Parmelee

P. A.

(Eds.), Physical illness and depression in older adults (pp. 11–29). New York: Kluwer Academic/Plenum Publishers.

Bruce

M. L.

, & Hoff

R. A.

(1994). Social and physical health risk factors for first-onset major depressive disorder in a community sample. Social Psychiatry and Psychiatric Epidemiology, 29, 165–171.

Bruce

M. L.

Seeman

T. E.

Merrill

S. S.

, & Blazer

D. G.

(1994). The impact of depressive symptomatology on physical disability: MacArthur Studies of Successful Aging. American Journal of Public Health, 84, 1796–1799.

Bruera

(1996). Patient assessment in palliative cancer care. Cancer Treatment Reviews, 22,(Suppl. A), 3–12.

Bruera

Kuehn

Miller

M. J.

Selmser

, & MacMillan

(1991). The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. Journal of Palliative Care, 7, 6–9.

Callahan

C. M.

Unverzagt

F. W.

Hui

S. L.

Perkins

A. J.

, & Hendrie

H. C.

(2002). Six-item screener to identify cognitive impairment among potential subjects for clinical research. Medical Care, 40, 771–781.

Chang

V. T.

Hwang

S. S.

, & Feuerman

(2000). Validation of the Edmonton Symptom Assessment Scale. Cancer, 88, 2164–2171.

10.

Colton

(1974). Statistics in medicine. Boston: Little, Brown.

11.

Cusick

Lawler

, & Swain

(1987). Chemotherapy, cancer, and the quality of life: An occupational therapy approach. Australian Journal of Occupational Therapy, 34, 105–113.

12.

de Jong

Candel

M. J.

Schouten

H. C.

Abu-Saad

H. H.

, & Courtens

A. M.

(2006). Course of the fatigue dimension “activity level” and the interference of fatigue with daily living activities for patients with breast cancer receiving adjuvant chemotherapy. Cancer Nursing, 29, E1–E13. doi:00002820-200609000-00013.

13.

Dodd

M. J.

Miaskowski

, & Paul

S. M.

(2001). Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum, 28, 465–470.

14.

Given

B. A.

Given

C. W.

Sikorskii

, & Hadar

(2007). Symptom clusters and physical function for patients receiving chemotherapy. Seminars in Oncology Nursing, 23, 121–126.

15.

Goodwin

J. A.

Coleman

E. A.

, & Shaw

(2006). Short Functional Dependence Scale: Development and pilot in older adults with cancer. Cancer Nursing, 29, 73–81.

16.

Hegel

M. T.

Lyons

K. D.

Hull

J. G.

Kaufman

Urquhart

(2010). Feasibility study of a randomized controlled trial of a telephone-delivered problem-solving occupational therapy intervention to reduce participation restrictions in rural breast cancer survivors undergoing chemotherapy. Psycho-Oncology. Advance online publication. doi:10.1002/pon.1830.

17.

Howlader

Noone

A. M.

Krapcho

Neyman

Aminou

Waldron

(Eds.). SEER Cancer Statistics Review, 1975–2008, National Cancer Institute. Bethesda, MD: National Cancer Institute. Accessed on June 9, 2011, at http://seer.cancer.gov/csr/1975_2008/results_merged/topic_prevalence.pdf.

18.

Katz

P. P.

, & Morris

(2007). Use of accommodations for valued life activities: Prevalence and effects on disability scores. Arthritis & Rheumatism, 57, 730–737.

19.

Katz

P. P.

Morris

, & Yelin

E. H.

(2006). Prevalence and predictors of disability in valued life activities among individuals with rheumatoid arthritis. Annals of the Rheumatic Diseases, 65, 763–769.

20.

Kroenke

, & Spitzer

R. L.

(2002). The PHQ-9: A new depression diagnostic and severity measure. Psychiatric Annals, 32, 1–7.

21.

Law

Baptiste

Carswell

McColl

M. A.

Polatajko

, & Pollock

(1998). Canadian occupational performance measure. Toronto: Canadian Association of Occupational Therapists.

22.

Leidy

N. K.

(1999). Psychometric properties of the functional performance inventory in patients with chronic obstructive pulmonary disease. Nursing Research, 48, 20–28.

23.

Massof

R. W.

Hsu

C. T.

Baker

F. H.

Barnett

G. D.

Park

W. L.

Deremeik

J. T.

(2005). Visual disability variables: I. The importance and difficulty of activity goals for a sample of low-vision patients. Archives of Physical Medicine and Rehabilitation, 86, 946–953.

24.

National Cancer Institute (2008, November 24). Chemotherapy side effects fact sheets. Retrieved from http://www.cancer.gov/cancertopics/chemo-side-effects.

25.

Portenoy

R. K.

Thaler

H. T.

Kornblith

A. B.

Lepore

J. M.

Friedlander-Klar

Kiyasu

(1994). The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. European Journal of Cancer, 30, 1326–1336.

26.

Portney

L. G.

, & Watkins

M. P.

(1993). Foundations of clinical research. Stamford, CT: Appleton & Lange.

27.

Rovner

B. W.

Casten

R. J.

Hegel

M. T.

Leiby

B. E.

, & Tasman

W. S.

(2007). Preventing depression in age-related macular degeneration. Archives of General Psychiatry, 64, 886–892.

28.

Sayers

S. P.

Jette

A. M.

Haley

S. M.

Heeren

T. C.

Guralnik

J. M.

, & Fielding

R. A.

(2004). Validation of the Late-Life Function and Disability Instrument. Journal of the American Geriatrics Society, 52, 1554–1559.

29.

Spitzer

R. L.

Kroenke

, & Williams

J. B.

(1999). Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Journal of the American Medical Association, 282, 1737–1744.

30.

Steinberg

E. P.

Tielsch

J. M.

Schein

O. D.

Javitt

J. C.

Sharkey

Cassard

S. D.

(1994). The VF-14: An index of functional impairment in patients with cataract. Archives of Ophthalmology, 112, 630–638.

31.

Tulman

, & Fawcett

(2007). Development of the Comprehensive Inventory of Functioning-Cancer. Cancer Nursing, 30, 205–212.

32.

Tanur

J. M.

(Ed.). (1992). Questions about questions: Inquiries into the cognitive bases of surveys. New York: Russell Sage Foundation.

33.

Ware

J. E.

Kosinski

Bjorner

J. B.

Turner-Bowker

D. M.

Gandek

, & Maruish

M. E.

(2007). User's manual for the SF-36v2 health survey. Lincoln, RI: QualityMetric Incorporated.